Acquisition

October 28, 2026 1. The Manager-Listing National Stock Exchange of India Limited (Scrip Symbol: NAUKRI) 2. The Manager-Listing BSE Limited (Scrip Code: 532777) Dear Sir/Madam, Subject: Outcome of the Board Meeting – October 28, 2026 Ref.: Intimation pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Pursuant to the requirements of Regulation 30 read with Schedule III of the Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, October 28, 2026, have, inter alia, considered and approved the following: a) Proposal to divest its entire holding (i.e. 14.18%) held in Medcords Healthcare Solutions Private Limited (‘Medcords’) on fully converted & diluted basis, through its wholly-owned subsidiary, Startup Investments (Holding) Limited (SIHL). A provision for impairment of full amount against said investment was booked in FY 2023-24. Post this divestment, Medcords will cease to be Joint Venture of the Company. b) Proposal to divest its entire holding (i.e. 31.64%) held in Unnati Online Private Limited (‘Unnati Online’) on fully converted & diluted basis (excluding ESOP Pool), through its wholly-owned subsidiary, Startup Investments (Holding) Limited (SIHL). A provision for impairment of full amount against said investment was booked in FY 2019-20. Post this divestment, Unnati Online will cease to be Associate Company of the Company. c) Investment of an amount of about Rs. 150 crores in Redstart Labs (India) Limited, wholly owned subsidiary of the Company. d) Basis the recommendation of the Nomination & Remuneration Committee, reconstitution of the Audit Committee (AC), by inducting Mr. Naresh Chand Gupta, Additional Director (Independent Category), as a member of the Committee, with effect from October 29, 2026. Post reconstitution, the composition of AC with effect from October 29, 2026 shall be as under: S.No. Name of the Member Category Position in the Committee 1. Mr. Sanjiv Sachar Independent Director Chairman 2. Ms. Geeta Mathur Independent Director Member 3. Ms. Radha Rajappa Independent Director Member 4. Mr. Naresh Chand Gupta Independent Director Member INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019 Further, the details as required in terms of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 in relation to the above referred items with respect to divestment and investment are enclosed as Annexure A to this intimation. The exchanges are also informed that the Board Meeting commenced at 10:30 a.m. and the aforesaid items have been considered and approved by the Board at 12:20 p.m. The same are hereby furnished to the Stock Exchanges, while the meeting continues for considering remaining agenda items at the time of this intimation and is expected to end around 01:30 p.m. This intimation is also being uploaded on Company’s website and can be accessed at www.infoedge.in. We request you to kindly take the above on record. Thanking You. Yours faithfully, For Info Edge (India) Limited Jaya Bhatia Company Secretary & Compliance Officer Encl.: as above INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019 Annexure-A Disclosure of information pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 a) Divestment of Company’s Stake held in Medcords Healthcare Solutions Private Limited through wholly owned subsidiary, Startup Investments (Holding) Limited (SIHL) S. No. Particulars Details 1. The amount and percentage of the turnover or Name: Medcords Healthcare Solutions Private Limited revenue or income and net worth contributed by (‘Medcords’) such unit or division or undertaking or Details as on March 31, 2026* subsidiary or associate company of the listed Amount (Rs. in Percentage entity during the last financial year crores) Total Income Networth Turnover Revenue *A provision for impairment of full amount against investment in Medcords was booked in FY 2023-24. Accordingly, Medcords has not contributed to any of the relevant financial parameters, including Total Income, Net Worth, Turnover and Revenue, in the consolidated financial statements of the Company for FY 2025–26. Therefore, the amounts and corresponding percentages attributable to Medcords in respect of the aforesaid financial parameters for FY 2025–26 have been mentioned as Nil. 2. Date on which the agreement for sale has been The agreement for sale shall be entered into within 30 days entered into from the Board’s approval. 3. The expected date of completion of The transaction of sale/disposal/divestment of the sale/disposal Company’s stake held in Medcords on fully converted and diluted basis i.e. 14.18% through its wholly-owned subsidiary SIHL, has been approved by the Board of Directors of the Company in its meeting held today, i.e. on October 28, 2026. The Company will submit an update on the aforesaid sale/disposal which is expected to be completed by January 27, 2027. 4. Consideration received from such About Rs. 5000. sale/disposal INFO EDGE (IN DIA) LIMITED Corporate Office: B-8, Sector - 132, Noida - 201304, Tel.: 0120 - 3082000, Fax: 0120-3082095 Email: investors@naukri.com URL: http://www.infoedge.in CIN: L74899DL1995PLC068021 Regd. Office: Ground Floor, 12A, 94, Meghdoot, Nehru Place, New Delhi-110019 5. Brief details of buyers and whether any of the The aforesaid Shareholding will be sold to Mr. Shreyans buyers belong to the promoter/ promoter Mehta, Director and Promoter of Medcords. group/group companies. If yes, details thereof Mr. Shreyans Mehta is Promoter and Director of Medcords. The buyer is not related to promoter/promoter group/group companies of the Company. 6. Whether the transaction would fall within related Transaction is not a Related Party Transaction for the party transactions? If yes, whether the same is Company. done at “arms length” 7. Whether the sale, lease or disposal of the Not Applicable. undertaking is outside Scheme of Arrangement? If yes, details of the same including compliance with regulation 37A of LODR Regulations 8. Additionally, in case of a slump sale, indicative Not Applicable. disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale b) Divestment of Company’s Stake held in Unnati Online Private Limited through wholly owned subsidiary, Startup Investments (Holding) Limited (SIHL) S. No. Particulars Details 1. The amount and percentage of the turnover or Name: Unnati Online Private Limited (‘Unnati Online’) revenue or income and net worth contributed by Details as on March 31, 2026* such unit or division or undertaking or Amount (Rs. in Percentage subsidiary or associate company of the listed crores) entity during the last financial year Total Income Networth Turnover Revenue *A provision for impairment of full amount against investment in Unnati Online was booked in FY 2019-20. Accordingly, Unnati Online has not contributed to any of the relevant financial parameters, including Total Income, Net Worth, Turnover and Revenue, in the consolidated financial statements of the Company for FY 2025–26. Therefore, the amounts and corresponding percentages attributable to Unnati Online in respect of the aforesaid financial parameters for FY 2025–26 have been mentioned as Nil. 2. Date on whi [Showing first 8,000 characters — download PDF for full document]